Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Gynecol Oncol. 2010 Jul 31;119(1):140–145. doi: 10.1016/j.ygyno.2010.06.024

Figure 2. Representative dose-response curves following exposure to patupilone versus paclitaxel of USPC primary cell lines with High versus Low HER-2/neu expression.

Figure 2

Survival was assessed by MTS assay as described in the Methods section. Each point on the cell line graph represents the mean of 3 estimations + SE.